| Purpose | Announcement Date | Split Date | Record Date | Face Value (before split) | Face Value (after split) |
|---|---|---|---|---|---|
| Split | 29 Nov 2025 | 20 Feb 2026 | 20 Feb 2026 | 10 | 2 |
| Outcome of Board Meeting pertaining to Sub-Division/Split of Equity Shares of Company. Sub-division/split of equity shares of the Company, such that 1 (One) equity share having face value of Rs. 10/- (Rupees Ten only) each, fully paid-up, be sub-divided into 5 (Five) equity shares having face value of Rs. 2/- (Rupees Two only) each, fully paid-up and consequential alteration(s) to the Memorandum of Association of the Company subject to the approval of the Members of the Company, by way of postal ballot and any regulatory/statutory approvals, as may be required under applicable laws. The Record date for the purpose of sub division/split of equity shares shall be intimated after seeking approval of the Members of the Company. The Board has approved the notice of Postal Ballot to seek necessary approval of the Members. The said Notice of Postal Ballot shall be submitted to the Stock Exchanges in due course in compliance with the provisions of the Listing Regulations. Intimation for Sub-division/Split of Equity Shares Trading Members of the Exchange are hereby informed that Titan Biotech Ltd, has fixed the Record Date for the purpose of Sub-Division of the Equity Shares of the Company :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE TITAN BIOTECH LTD (524717) RECORD DATE 20.02.2026 PURPOSE Sub-Division of existing Equity Shares from One Equity Share of Rs.10/- each into Five Equity Shares of Rs.2/- each. SUB-DIVIDED PAID-UP VALUE Rs.2/- SUB-DIVIDED PAID-UP VALUE W.E.F. 20/02/2026 DR-825/2025-2026 Note: - i. ISIN No. INE150C01011 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 20/02/2026. ii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 21.01.2026) New ISIN :INE150C01029 Source : NSDL Date: 03.02.2026 In Continuation to the Exchange Notice No. 20260121-38 dated January 21, 2026, Trading Members of the Exchange are hereby informed that the New ISIN number for the Sub-Divided Equity Shares of the Company will be as under: - Company Name & Scrip Code TITAN BIOTECH LTD (524717) New ISIN No. INE150C01029 Remarks Sub-division of Equity Shares from Rs.10/- to Rs. 2/- The new ISIN number given above, for Equity Shares of Rs.2/- each of the Company shall be effective for trades done on and from the Ex-Date i.e. 20-02-2026 (DR- 825/2025-2026) (As Per BSE Notice Dated on 17.01.2026) Intimation pertaining to credit confirmation of Equity Shares from the depositories regarding Sub-Division/Split of Equity Shares of the Company. (As Per BSE Announcement Dated on 27.02.2026) | |||||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
